Utility of PET/CT in patients with stage I-III melanoma

被引:9
|
作者
Aviles Izquierdo, J. A. [1 ]
Molina Lopez, I. [1 ]
Sobrini Morillo, P. [2 ]
Marquez Rodas, I. [3 ,4 ]
Mercader Cidoncha, E. [5 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Serv Dermatol, Calle Dr Esquerdo 46, Madrid 28007, Spain
[2] Univ Complutense Madrid, Fac Med, Madrid, Spain
[3] Hosp Gen Univ Gregorio Maranon, Serv Oncol Med, Madrid, Spain
[4] Ciberonc, Madrid, Spain
[5] Hosp Gen Univ Gregorio Maranon, Serv Cirugia Gen, Madrid, Spain
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2020年 / 22卷 / 08期
关键词
Melanoma; Diagnosis; Staging; PET; CT; Sentinel lymph node biopsy; Complete lymph node dissection; Skin metastases; F-18-FDG PET/CT; TOMOGRAPHY; CT;
D O I
10.1007/s12094-019-02252-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To study the utility of positron emission tomography with computerized tomography (PET/CT) in patients with a stage I-III melanoma. Patients and methods PET/CT findings from all patients with a stage I-III melanoma attended at our hospital from September 2011 to November 2015 were reviewed. Results Data from 83 patients with a stage I-III melanoma, 39 patients with a positive sentinel lymph node biopsy (SLNB) and 35 patients with locoregional recurrences were analyzed. Sensitivity of PET/CT in clinical stage I-III patients was 5%, with a 14% of false positives. In patients with a positive SLNB, PET/CT previous to complete lymph node dissection had a 23% of false negatives. In patients with clinical locoregional recurrences, PET/CT findings revealed asymptomatic visceral distant metastasis in 25.7%. Conclusions PET/CT has a significant rate of false positive and negative results in patients with a stage I-III melanoma. Utility in patients with nodal locoregional recurrences seems higher than in patients with skin metastases.
引用
收藏
页码:1414 / 1417
页数:4
相关论文
共 50 条
  • [1] Utility of PET/CT in patients with stage I–III melanoma
    J. A. Avilés Izquierdo
    I. Molina López
    P. Sobrini Morillo
    I. Márquez Rodas
    E. Mercader Cidoncha
    Clinical and Translational Oncology, 2020, 22 : 1414 - 1417
  • [2] Utility of PET/CT for surveillance of asymptomatic patients with resected stage III or IV melanoma
    Leon-Ferre, Roberto Antonio
    Kottschade, Lisa A.
    Lowe, Val J.
    Markovic, Svetomir
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Evaluation of PET/CT in patients with stage III malignant cutaneous melanoma
    Groen, Lennaert C. B.
    Lazarenko, Sergiy V.
    Schreurs, Hermien W. H.
    Richir, Milan C.
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 9 (02): : 168 - 175
  • [4] DOES 18FDG-PET/CT MODIFY THE TREATMENT STRATEGY IN STAGE I-III BREAST CANCER PATIENTS?
    Valli, M. C.
    Fozza, A.
    Pesce, G.
    Azinwi, N. C.
    Martucci, F.
    Ceriani, L.
    Richetti, A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S234 - S234
  • [5] Does 18FDG-PET/CT modify the treatment strategy in stage I-III breast cancer patients?
    Valli, M.
    Fozza, A.
    Martucci, F.
    Azinwi, C. N.
    Pesce, G.
    Ceriani, L.
    Richetti, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (09) : 602 - 602
  • [6] Soluble interleukin-2 receptor in stage I-III melanoma
    Ottaiano, A
    Leonardi, E
    Simeone, E
    Ascierto, PA
    Scala, S
    Calernma, R
    Bryce, J
    Caracò, C
    Satriano, RA
    Gianfranco, N
    Franco, R
    Botti, G
    Castello, G
    CYTOKINE, 2006, 33 (03) : 150 - 155
  • [7] Sensitivity, Specificity and the Diagnostic Accuracy of PET/CT for Axillary Staging in Patients With Stage I-III Cancer: A Systematic Review of The Literature
    Kasem, Judi
    Wazir, Umar
    Mokbel, Kefah
    IN VIVO, 2021, 35 (01): : 23 - 30
  • [8] Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CT
    Teixeira, Suzana C.
    Rebolleda, Jose Ferrer
    Koolen, Bas B.
    Wesseling, Jelle
    Jurado, Raul Sanchez
    Stokkel, Marcel P. M.
    Santiago, Maria del Puig Cozar
    van der Noort, Vincent
    Rutgers, Emiel J. Th.
    Olmos, Renato A. Valdes
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2016, 206 (06) : 1307 - 1314
  • [9] Treatment of stage I-III periodontitis
    Reena Wadia
    British Dental Journal, 2020, 229 (6) : 375 - 375
  • [10] The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanoma
    Ravichandran, Surya
    Nath, Neel
    Jones, David C.
    Li, Gabriel
    Suresh, Visakha
    Brys, Adam K.
    Hanks, Brent A.
    Beasley, Georgia M.
    Salama, April K. S.
    Howard, Brandon A.
    Mosca, Paul J.
    SURGICAL ONCOLOGY-OXFORD, 2020, 35 : 533 - 539